ATL/TV1102 Trial Results Presented At World Congress On Treatment And Research In Multiple Sclerosis (Medical News Today)

Antisense Therapeutics Ltd. (ASX: ANP) and Isis Pharmaceuticals, Inc. Continue…

No comments yet. Be the first.

Leave a reply

You must be logged in to post a comment.